Interferon alfa-2b biosimilar (Pharmapark)

干扰素α-2b生物类似药 (Pharmapark)

Report date: 2022/02/17 14:37:22

Base Information

Drug NameInterferon alfa-2b biosimilar (Pharmapark)

Drug Alias Name干扰素α-2b生物仿制药 (Pharmapark)Altevir

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsNeoplasmsHepatitis C

Global Approved IndicationsNeoplasmsHepatitis C

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved Date2007/12/01

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesPharmapark

China Registration ClassN/A

Active CompaniesPharmapark

Inactive CompaniesN/A

Active IndicationsNeoplasmsHepatitis C

Inactive IndicationsN/A

ATC CodeL03AB05